RTW INVESTMENTS, LP
Institutional investor · Portfolio as of Q3 2022
Top Holdings86 positions
Alnylam Pharmaceuticals Inc | 1.7M | $336.9M | 7.8% | $94.58 | +121.39% | 15 qtrssince 2019-Q1 | Unchanged 0 |
PTC Therapeutics Inc | 5.6M | $282.2M | 6.5% | $42.53 | +18.38% | 15 qtrssince 2019-Q1 | Increased 67 |
Rocket Pharmaceuticals Inc | 15.8M | $252.2M | 5.8% | $18.70 | -24.92% | 15 qtrssince 2019-Q1 | Unchanged 0 |
Thermo Fisher Scientific Inc | 435,500 | $220.9M | 5.1% | $570.15 | -10.24% | 5 qtrssince 2021-Q3 | Unchanged 0 |
IMMUNOCORE HLDGS PLC | 4.5M | $209M | 4.8% | $38.10 | +20.30% | 7 qtrssince 2021-Q1 | Increased 63 |
Masimo Corp | 1.4M | $203.3M | 4.7% | $175.41 | -18.81% | 15 qtrssince 2019-Q1 | Increased 60 |
PROMETHEUS BIOSCIENCES INC | 3.2M | $188.2M | 4.3% | — | — | 7 qtrssince 2021-Q1 | Unchanged 0 |
ARGENX SE-ADR | 467,195 | $164.9M | 3.8% | $328.90 | +7.34% | 15 qtrssince 2019-Q1 | Increased 59 |
Penumbra Inc | 698,371 | $132.4M | 3.1% | $262.94 | -27.05% | 5 qtrssince 2021-Q3 | Unchanged 0 |
Mirati Therapeutics Inc | 1.9M | $131.5M | 3.0% | — | — | 15 qtrssince 2019-Q1 | Unchanged 0 |
ESTABLISHMENT LABS HLDGS INC | 2.4M | $129.4M | 3.0% | $22.63 | +133.75% | 15 qtrssince 2019-Q1 | Unchanged 0 |
Cytokinetics Inc | 2.6M | $124.7M | 2.9% | $27.00 | +79.43% | 9 qtrssince 2020-Q3 | Increased 52 |
Illumina Inc | 564,375 | $107.7M | 2.5% | $320.70 | -41.21% | 9 qtrssince 2020-Q3 | Unchanged 0 |
Relmada Therapeutics Inc | 2.6M | $97.9M | 2.3% | $32.16 | +12.54% | 12 qtrssince 2019-Q4 | Increased 51 |
Ultragenyx Pharmaceutical Inc | 2.4M | $97.7M | 2.3% | $66.25 | -37.49% | 4 qtrssince 2021-Q4 | Increased 77 |
NATERA INC | 2.2M | $96.8M | 2.2% | $43.23 | +1.36% | 13 qtrssince 2019-Q3 | Increased 53 |
CELLDEX THERAPEUTICS INC NEW | 3.1M | $86.7M | 2.0% | $14.23 | +99.18% | 10 qtrssince 2020-Q2 | Unchanged 0 |
AVIDITY BIOSCIENCES INC | 5.2M | $84.4M | 1.9% | $25.69 | -34.90% | 10 qtrssince 2020-Q2 | Increased 51 |
AXSOME THERAPEUTICS INC | 1.9M | $84M | 1.9% | $48.56 | -9.09% | 15 qtrssince 2019-Q1 | Increased 54 |
Cutera Inc | 1.8M | $80.7M | 1.9% | — | — | 6 qtrssince 2021-Q2 | Unchanged 0 |
RTW INVESTMENTS, LP manages $4.3B across 86 positions as of Q3 2022. Top holdings: ALNY (7.8%), PTCT (6.5%), RCKT (5.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3.5/5.0.
Active quarter - 4 new positions, 25 exits, 17 increased. Top move: RARE (INCREASED, conviction 77). Portfolio: $4.3B across 86 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR